Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Catheter Precision (VTAK) Equity Average (2018 - 2025)

Historic Equity Average for Catheter Precision (VTAK) over the last 8 years, with Q3 2025 value amounting to $6.8 million.

  • Catheter Precision's Equity Average fell 5000.18% to $6.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.8 million, marking a year-over-year decrease of 5000.18%. This contributed to the annual value of $16.5 million for FY2024, which is 819.95% up from last year.
  • According to the latest figures from Q3 2025, Catheter Precision's Equity Average is $6.8 million, which was down 5000.18% from $7.4 million recorded in Q2 2025.
  • Catheter Precision's 5-year Equity Average high stood at $29.8 million for Q2 2023, and its period low was $6.8 million during Q3 2025.
  • For the 5-year period, Catheter Precision's Equity Average averaged around $16.3 million, with its median value being $16.4 million (2024).
  • Its Equity Average has fluctuated over the past 5 years, first surged by 11382.13% in 2023, then crashed by 5522.37% in 2025.
  • Over the past 5 years, Catheter Precision's Equity Average (Quarter) stood at $17.6 million in 2021, then crashed by 38.19% to $10.9 million in 2022, then skyrocketed by 97.8% to $21.5 million in 2023, then plummeted by 42.91% to $12.3 million in 2024, then tumbled by 44.8% to $6.8 million in 2025.
  • Its Equity Average was $6.8 million in Q3 2025, compared to $7.4 million in Q2 2025 and $9.8 million in Q1 2025.